Crim, Courtney http://orcid.org/0000-0002-3391-2490
Gotfried, Mark
Spangenthal, Selwyn
Watkins, Michael
Emmett, Amanda
Crawford, Catriona
Baidoo, Charlotte
Castro-Santamaria, Ramiro
Funding for this research was provided by:
GSK
Article History
Received: 31 May 2018
Accepted: 20 April 2020
First Online: 4 May 2020
Ethics approval and consent to participate
: The study protocol and informed consent forms were reviewed and approved by IntegReview Institutional Review Board (3815 S. Capital of Texas Highway, Suite 320, Austin, Texas,78704, United States) in accordance with the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practice (GCP) guidelines.The study was conducted in accordance with GCP and the ethical principles outlined in the Declaration of Helsinki (2008). All subjects provided written, informed consent prior to study participation.
: Not applicable.
: CB, RC-S, C Crim, C Crawford and MW are employees of, and hold shares, in GSK. AE is a former employee of, and holds shares in, GSK. MG has participated in speakers’ bureau for GSK, and has received grants from Boehringer Ingelheim, Sunvovion, AstraZeneca, Theravance, Pearl, and Chiesi. SS has received personal fees from GSK in connection with participation in a speakers’ bureau.